MetLife Investment Management LLC Sells 4,588 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• MetLife Investment Management LLC sold 4,588 shares of UnitedHealth Group, reducing its position by 1.9% but still holding approximately 241,748 shares, valued at $126.6 million.
• The CEO of UnitedHealth Group, Patrick Hugh Conway, sold 589 shares of the company's stock, representing a 5.36% decrease in his ownership.
• UnitedHealth Group announced a quarterly $2.21 dividend, with a dividend yield of 2.9%, to be paid on September 23rd to investors of record.

MetLife Investment Management LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 241,748 shares of the healthcare conglomerate's stock after selling 4,588 shares during the period. UnitedHealth Group makes up approximately 0.7% of MetLife Investment Management LLC's holdings, making the stock its 19th biggest position. MetLife Investment Management LLC's holdings in UnitedHealth Group were worth $126,616,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the 4th quarter valued at approximately $26,000. Bayforest Capital Ltd raised its position in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its position in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares during the last quarter. Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group in the 4th quarter worth about $41,000. Finally, Copia Wealth Management purchased a new position in UnitedHealth Group in the 4th quarter worth about $42,000. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Up 1.2%

UNH stock opened at $307.0980 on Friday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market capitalization of $278.13 billion, a price-to-earnings ratio of 13.31, a PEG ratio of 1.98 and a beta of 0.43. The business has a 50 day simple moving average of $288.39 and a two-hundred day simple moving average of $388.53.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the company earned $6.80 earnings per share. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on UNH shares. Bank of America upped their price target on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research report on Monday, August 18th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating for the company in a research report on Wednesday. HSBC reaffirmed a "reduce" rating and set a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. TD Cowen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a research report on Monday, May 19th. Finally, Truist Financial reduced their target price on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a report on Wednesday, July 16th. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average price target of $365.38.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.